Condition: Opioid Use Disorder · Sponsor: Yale University
The purpose of this clinical trial is to compare the effectiveness of office-based methadone with pharmacy administration and/or dispensing to office-based buprenorphine for the treatment of opioid use disorder. This study will also examine factors influencing the implementation of office-based methadone.
This description comes directly from the study's public registry record.
Jessica Research Associate · 203-785-6821 · j.mckenzie@yale.edu
Melissa Gordon · 203-937-3486 · melissa.gordon@yale.edu
Always discuss trial participation with your own doctor first.
| Highland Hospital Bridge Clinic at Alameda Health System | Oakland, California, United States | Recruiting |
| Outpatient Buprenorphine Induction Clinic, University of California, San Francisco | San Francisco, California, United States | Recruiting |
| Rapid Start Clinic, Kaiser Permanente Colorado | Denver, Colorado, United States | Recruiting |
| Officed Based Addiction Treatment Program, Boston Medical Center | Boston, Massachusetts, United States | Recruiting |
| Hennepin Healthcare Addiction Medicine | Minneapolis, Minnesota, United States | Recruiting |
| Marshall University Division of Addiction Sciences P.R.O.A.C.T | Huntington, West Virginia, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06323824